High-yield muni bond funds and ETFs collected sizable inflows over the past year — and investors are getting attractive returns.
JPMorgan’s top biopharma picks for 2025
The Nasdaq Biotechnology Index (NBI) has gained 6.5% this year, outpacing gains from both the S&P 500 and tech-heavy Nasdaq Composite.
Josh Brown says Palantir is now trapped in a ‘no-man’s land’ after stock momentum breaks
Palantir shares saw steep declines for a second straight day on Thursday.
This airline stock could be starting a new downtrend phase, according to the charts
David Keller breaks down the charts on American Airlines.
Stock-picking hedge funds flock into numerous hidden-gem stocks that are beating the market
Several hidden gems gained popularity among the smart-money community last quarter, including insurance broker Arthur J. Gallagher.
Defense stocks are in focus because of possible spending cut. How to play it with options
Mike Khouw describes a put spread on RTX.
Cruise stocks tumble after Commerce Secretary Lutnick signals tax crackdown
Royal Caribbean was the hardest hit.
DA Davidson recommends speculative IonQ, saying Microsoft breakthrough shows ‘quantum race is accelerating’
Shares of IonQ could rally 46% from current levels as Microsoft’s Majorana 1 validates the entire quantum computing industry, the broker said.
Goldman is bullish on this Chinese self-driving company as an AI play
The Wall Street bank sees shares rising about 22% from Wednesday’s close.
Palantir shares drop 6%, falling for a second day as retail traders’ latest cult trade starts to unwind
Shares dropped around 10% in Wednesday’s session.